This study describes how using whole genome sequencing with deep amplicon sequencing we have been able to identify and validate new drug resistance mutations in first-line anti TB antibiotics.
A complete and effective mNGS workflow was built which could provide accurate and timely pathogen detection for pneumonia in various respiratory samples.
